Oscar Health closes $225M funding round

A photo of a billboard for Oscar Health
Oscar Health has released the results of its latest funding round. (Oscar Health)

Tech-enabled insurer Oscar Health has closed its latest funding round for $225 million.

The round included investment from previous backers including Google's parent company Alphabet, Khosla Ventures and Thrive Capital, along with new investors Baillie Gifford and Coatue, Oscar announced Friday.

Oscar said the funding round puts it in a strong position to continue growing off of its $2 billion revenue base.


Learn What 1,000 People Said About Their Virtual Care Experiences During COVID-19

72% of patients had their first virtual visit during the pandemic and most now want it as a permanent option. Learn what else our survey revealed about their experiences with virtual visits, preferences for scheduling them, and more.

RELATED: How Oscar Health is harnessing its tech-enabled DNA amid the COVID-19 crisis 

“At Oscar, we combine our full-stack technology platform and data-driven approach to deliver seamless care that meets members where they are. We have created an experience that feels like you have a doctor in the family," said CEO Mario Schlosser in a statement. "This funding enables us to further accelerate the development of our unique model while creating efficiencies and cost-savings.”

After launching a notable expansion earlier this year, Oscar now operates in 15 states and 29 markets across the U.S., covering more than 420,000 members. It also joined forces with Cigna to launch co-branded plans targeting small businesses.


Suggested Articles

Healthcare employment continued to recover in June as the sector gained 358,000 jobs, with hospitals starting to add jobs after losses in May.

While the COVID-19 pandemic has wreaked financial havoc across healthcare, it did not stymie mergers and acquisition deals as much as anticipated.

Some labs are starting to reach capacity for COVID-19 testing amid a major spike in cases across sunbelt states, HHS reported.